Jennifer Lew
CIK 1465994 · EVP & CHIEF FINANCIAL OFFICER · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$804.0K
Companies
4
Total Filings
55
Lifetime Open-Market Net
-$2.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANNX | EVP & CHIEF FINANCIAL OFFICER | 170,700 | $4.71 | $804.0K | -$401.8K | 20 | 2026-03-04 |
| BOLD | Director | — | $1.41 | — | $0 | 2 | 2025-06-23 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Chief Financial Officer | 147,299 | — | — | -$1.56M | 27 | 2019-05-03 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | VP, Finance & PAO | 21,082 | $15.50 | $326.8K | -$84.9K | 6 | 2013-02-07 |
Recent Filings · Page 2 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-21 | ANNX | Mixed | +36,407 | -$14.3K | EDGAR |
| 2024-02-14 | ANNX | Sell (S) | −1,809 | -$10.0K | EDGAR |
| 2024-01-23 | ANNX | Sell (S) | −1,057 | -$4.1K | EDGAR |
| 2023-02-21 | ANNX | Grant (A) | +18,975 | $0 | EDGAR |
| 2023-02-15 | ANNX | Sell (S) | −1,908 | -$12.0K | EDGAR |
| 2022-07-13 | ANNX | Grant (A) | +9,375 | $0 | EDGAR |
| 2022-02-15 | ANNX | Grant (A) | +12,500 | $0 | EDGAR |
| 2021-09-15 | ANNX | Mixed | — | -$43.8K | EDGAR |
| 2021-06-01 | ANNX | Mixed | — | -$51.6K | EDGAR |
| 2021-03-25 | ANNX | Mixed | — | -$104.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.